BioFire Defense

06/01/2026

What an incredible week at the Military Health Systems (MHS) Conference!

Thank you to all the clinicians and partners who stopped by our booth to discuss the future of diagnostic readiness.

We look forward to continuing our partnership and supporting your mission with gold-standard syndromic technology.

05/27/2026

The Centers for Disease Control and Prevention (CDC) has issued a Health Alert Network (HAN) Health Advisory (HAN 00530) regarding the ongoing Ebola outbreak in the Democratic Republic of the Congo and Uganda.

This advisory alerts clinicians and public health professionals to remain vigilant as the region responds to cases caused by the rare Bundibugyo virus strain. Currently, there are no FDA-licensed vaccines or targeted therapeutics specifically for this strain, making clinical awareness, thorough travel history assessments, and prompt diagnostic capabilities the critical first line of defense.

To support global preparedness and response efforts, BioFire Defense is actively increasing our production capacity for critical testing resources. The BioFire® Global Fever Special Pathogens (GF SP) Panel can detect multiple Ebola species, including Bundibugyo, helping healthcare facilities identify high-consequence pathogens quickly and accurately with results in about an hour.

We remain dedicated to working with U.S. Government partners, global public health agencies, and healthcare institutions to strengthen outbreak response efforts and preparedness activities.

Learn more about the GF SP Panel:

Ebola, Bundibugyo, Reston, Sudan, Taï Forest, Zaire

05/25/2026

Today, we pause to remember the brave men and women who gave everything in service to our nation. Their sacrifice is the foundation of our freedom and the ultimate reminder of why the mission matters.

At BioFire Defense, we are humbled to support those who serve. We honor the fallen by remaining steadfast in our commitment to protecting the health and readiness of those who continue to stand on the front lines.

05/21/2026

A recent Reuters report on the Ebola response in the DRC highlights a critical challenge: testing for a comprehensive list of targets is vital.

To help support global preparedness efforts, BioFire Defense is actively increasing our production capacity for critical testing resources. The BioFire® Global Fever Special Pathogens (GF SP) Panel can detect multiple high consequence pathogens simultaneously in a single run, such as multiple Ebola species, including Bundibugyo.

As shared in the report, “BioFire Defense is actively engaging with public health stakeholders and international contacts to monitor the evolving outbreak situation and assess potential support needs.” We remain committed to working alongside our global health partners to help optimize resources and deliver fast and reliable results in the field.
Learn more about the GF SP Panel:

Ebola, Bundibugyo, Reston, Sudan, Taï Forest, Zaire

05/19/2026

The World Health Organization (WHO) has declared the Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern (PHEIC).

This escalation is driven by the rare Bundibugyo strain of the virus, which has now crossed borders from the Ituri province of the DRC into Kampala, Uganda. Unlike the more common Zaire ebolavirus strain, there are currently no approved vaccines or targeted therapeutics for the Bundibugyo strain.
Tracking a cross-border outbreak requires identifying cases inside the critical early window before the virus spreads through communities and health systems.

BioFire Defense is committed to supporting global health security in these high-stakes environments. The BIOFIRE® Global Fever Special Pathogens (GFSP) Panel is built for exactly this type of crisis, delivering laboratory-grade identification of rare, high-consequence pathogens, including Ebola, in under an hour.
By putting fast, comprehensive, and accurate testing directly in the hands of clinical teams, we provide actionable intelligence when every minute counts toward containment.

Learn more about the GFSP Panel:

Ebola, Bundibugyo, Reston, Sudan, Taï Forest, Zaire

05/19/2026

We are heading to Dallas for the Military Health Systems (MHS) Conference to showcase how the BIOFIRE® ecosystem provides a diagnostic shield for the frontline.

Stop by Booth #722 to learn about our world-class IVD diagnostic solutions. Our high-plex syndromic panels are engineered to eliminate guesswork and move clinicians toward a decisive treatment plan in minutes.

We look forward to meeting with current and future partners to discuss how we can support your goals and ensure unit readiness.

05/18/2026

Biothreat detection doesn’t always happen in a controlled environment. When the mission requires reliable, on-the-spot environmental surveillance, the BIOFIRE® RAZOR® delivers lab-grade molecular results in a truly portable package.

Built for the field, the RAZOR is designed to identify high-consequence threats wherever the mission takes you. It’s compact, rugged, and fast; ensuring you have the actionable intelligence needed to secure your surroundings with confidence.

05/16/2026

To those who serve at home and abroad, we thank you for your unwavering commitment to the mission.

At BioFire Defense, our work is driven by the goal of keeping our Armed Forces healthy, ready, and resilient. Today, we honor the dedication and sacrifice of the men and women across every branch of the military.

05/15/2026

Biothreats are ever-present and evolve quickly. For those on the front lines, getting fast, reliable answers in the field is essential for timely response and effective containment. BioFire Defense delivers agile and accurate molecular detection solutions designed for the unique demands of first responders. Our systems provide comprehensive results ensuring you have the actionable intelligence required to protect communities and mitigate risks, even in the most challenging and high-pressure environments. We are committed to equipping you with the tools to respond swiftly and decisively.

Follow us for the latest in diagnostic intelligence.

05/13/2026

True readiness means having total awareness in situations involving unknown febrile illnesses or exposures to high-consequence pathogens. The BioFire® Global Fever Special Pathogens Panel is designed to provide fast, comprehensive answers when every second counts in a clinical setting.

Its ability to detect 16 diverse pathogens from a single sample minimizes the need for multiple tests, the Global Fever Special Pathogens Panel streamlines workflow and potentially enables faster clinical decisions.

Explore the Global Fever Special Pathogens Panel: https://biofiredefense.com/biofire-global-fever-special-pathogens-gfsp-panel/